United States Ophthalmic Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (undefined)

United States Ophthalmic Market is Segmented By Drug Class (Anti-inflammatory Drugs, Anti-infective Drugs, Anti-glaucoma Drugs, Anti-VEGF Agents, and Others), By Dosage Form (Eye Drops, Ointments, Gels, Solutions, Injections, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Indication (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies). The report offers the value (in USD billion) for the above-mentioned segments.

Competitive overview of United States Ophthalmic Market

The major players operating in the United States ophthalmic market include Novartis AG, AbbVie, Merck & Co., Inc, Bausch Health Companies Inc., Santen Pharmaceutical Co., Ltd., Regeneron Pharmaceuticals, Inc., Sun Pharmaceutical Industries Ltd., Ocular Therapeutix, Inc., Alcon, KALA BIO, Aequus Pharmaceuticals, Omeros CorporationTakeda Pharmaceutical Company Limited, Eyenovia, Inc., Nicox, and other prominent players.

United States Ophthalmic Market Leaders

  • Novartis AG
  • AbbVie
  • Merck & Co., Inc
  • Bausch Health Companies Inc.
  • Santen Pharmaceutical Co., Ltd.
*Disclaimer: Major players are listed in no particular order.

United States Ophthalmic Market - Competitive Rivalry, 2023

Market Concentration Graph

United States Ophthalmic Market

Market Consolidated
(Dominated by major players)
Market Fragmented
(Highly competitive with lots of players.)
*Source: Coherent Market Insights